Home/Filings/4/0001104659-13-050864
4//SEC Filing

BIOSANTE PHARMACEUTICALS INC 4

Accession 0001104659-13-050864

$ANIPCIK 0001023024operating

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 8:33 PM ET

Size

7.6 KB

Accession

0001104659-13-050864

Insider Transaction Report

Form 4
Period: 2013-06-19
Brown Robert E. JR
Director10% Owner
Transactions
  • Award

    Common Stock

    2013-06-19+16,918,46916,918,469 total(indirect: See Footnote)
Penn Thomas A.
Director10% Owner
Transactions
  • Award

    Common Stock

    2013-06-19+16,918,46916,918,469 total(indirect: See Footnote)
Footnotes (2)
  • [F1]On June 19, 2013, the issuer's wholly-owned subsidiary merged with ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. (ANI). Holders of ANI's series D preferred stock received shares of the issuer's common stock as merger consideration. Meridian Venture Partners II, L.P. (MVP II) acquired the number of shares of issuer common stock shown in the table in exchange for its shares of ANI series D preferred stock. Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of MVP II. MVP Management Company (MVP Management) d/b/a MVP Capital Partners, is the management company for MVP II and also renders financial and business advisory services to several of the companies in which MVP II has invested.
  • [F2]Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., the sole stockholder, director and President of MVP Management, as well as a limited partner of GP and one of two principals of MVP II that are licensed by the Small Business Administration (SBA). Thomas A. Penn, a director of the issuer, is a Vice President of MVP Corp., a Vice President and employee of MVP Management, a limited partner of GP and one of the two SBA-licensed principals of MVP II. Messrs. Brown and Penn disclaim beneficial ownership in such shares of issuer common stock except to the extent of their respective pecuniary interests therein.

Documents

1 file

Issuer

BIOSANTE PHARMACEUTICALS INC

CIK 0001023024

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001023024

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 8:33 PM ET
Size
7.6 KB